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Abstract 
Obstructive Sleep Apnoea (OSA) is a common sleep disorder associated with significant 
health, quality of life and psychosocial problems. The aims of this review are to investigate 
the contribution of psychological constructs and theory to the assessment and treatment of 
OSA. Adherence to CPAP treatment remains a primary concern for improving treatment 
outcomes for OSA. Modifiable, psychological constructs of self-efficacy, coping, social 
support, treatment satisfaction and self-reported daytime sleepiness improve the prediction 
of CPAP adherence. These predictors are particularly robust in the context of a theoretical 
model. Social Cognition Theory (SCT) and Health Belief Model (HBM) are emerging as 
promising psychological models for understanding patient acceptance and adherence to 
CPAP treatment. An overview of psychologically informed interventions for CPAP use is 
presented. Education based interventions have promise, but the strongest and robust 
findings are emerging from theory-driven interventions. Specifically, Cognitive 
Behaviourally informed interventions and Motivational Interventions demonstrate 
consistent and large effect sizes in improving CPAP adherence rates.  
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THE PSYCHOLOGY OF OBSTUCTIVE SLEEP APNOEA:  
A THEORETICAL APPROACH TO TREATMENT ADHERENCE AND 
INTERVENTION 
Obstructive Sleep Apnoea (OSA) is a common sleep disorder characterised by 
collapse of the upper airway during sleep. Continuous Positive Airway Pressure Therapy 
(CPAP) is the most effective treatment for this disorder, but is consistently associated with 
suboptimal adherence rates. Unitary, modifiable psychological predictors of adherence have 
only recently been investigated from a theoretical perspective. Investigation of the theorised 
inter-relationships between these predictors, accounting for moderating and mediating 
relationships between them, has been lacking. This has resulted in much inconsistency in 
the literature.  
Previous research investigating modifiable psychological constructs of CPAP 
adherence will be critically reviewed. The primary goal of this review is to present a new,  
integrated, theoretically sound psychological model of CPAP adherence that predicts 
patient acceptance and adherence to treatment. It will be argued that this model will 
provide a basis for the development of psychological interventions designed to improve 
overall CPAP adherence rates and treatment outcomes. 
Clinical Presentation and Health Consequences of Obstructive Sleep Apnoea 
Obstructive Sleep Apnoea (OSA) is associated with obstructions of the upper 
airway during sleep, which are caused by collapse of the dilator muscles and soft tissues of 
the pharyngeal wall. OSA may be diagnosed based on the presence of 5 or more of these 
respiratory events (Apnoea-Hypopnoea Index > 5) with concurrent evidence of OSA 
symptoms (daytime sleepiness, snoring and choking arousals from sleep). Alternatively, 
OSA is also diagnosed when patients display an AHI of greater than 15 events per hour 
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with no subjective report of these additional symptoms (Chesson et al., 1997; ICSD-2, 
2005; Malhotra & White, 2002).  
The two main clinical features of OSA are the respiratory disturbances, and the 
arousals from sleep needed to reinstate breathing. These two features lead to the two main 
clinical consequences of the disorder, hypoxia of the brain and the heart, and sleep 
fragmentation. Daytime sleepiness and hypoxia of the brain are associated with cognitive 
deficits, such as impaired working memory and attention (Aloia, Ilniczky, Di Dio, Perlis, 
Greenblatt, & Giles, 2003; Gale & Hopkins, 2004). Hypoxia of the heart increases the risk 
of heart problems including hypertension (Coughlin, Mawdsley, Mugarza, Wilding & 
Calverley, 2007; ICSD-2, 2005; Jordan et al., 2005; Malhotra & White, 2002). Patients with 
OSA are also at higher risk for Type II diabetes and stroke (Malhotra & White, 2002). 
Daytime sleepiness effects the patients’ and their partner’s quality of life (Parish & Lyng, 
2003) and there is a high rate of comorbid anxiety and depression in this sample (ICSD-2, 
2005; Kingshott, Vennelle, Hoy, Engleman, Deary & Douglas, 2000; Parish & Lyng, 2003; 
Patel, White, Malhotra, Stanchina, & Ayas, 2003; Veale, Poussin, Benes, Pepin, & Levy, 
2002). The effects of sleepiness and impaired concentration is most obvious in the car 
accident risk odds-ratio of 7.3 over five years compared to individuals of similar 
demographic status without OSA (Young, Peppard, & Gottlieb, 2002).  
Prevalence of OSA 
The prevalence of OSA varies according to the defined criteria (ICSD-2, 2005). 
When the criteria for diagnosis requires an AHI>5 and self-reported daytime sleepiness, 
snoring and/or choking arousals, the estimated American prevalence of OSA is 4% for men 
and 2% for women. Up to 24% of men and 9% of women in the population have an AHI >5 
without any associated symptoms of sleepiness, snoring or choking arousals (American 
Academy of Sleep Medicine, 1999; ICSD-2, 2005; Malhotra & White, 2002; Young et al., 
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2002). Sleep apnoea is consistently more prevalent in males, with a male to female ratio of 
up to 8:1 (Perlis & Lichstein, 2003).  
Treatment of OSA 
The current “Gold Standard” treatment for OSA is CPAP therapy. Pressurised air is 
administered through a nasal (nCPAP) or full face mask. This pressurised air functions as a 
pneumatic splint for the upper airway, preventing it from collapse. The pressure is titrated 
to a level that reduces the individual patient’s AHI to less than 5 events per hour (Malhotra, 
Ayas, & Epstein, 2000; Stepnowsky & Moore, 2003).  
CPAP use reduces the risk of several adverse outcomes of OSA. There is a general 
reduction in the number of physician claims and in the length of hospital stays for patients 
on CPAP (Malhotra et al., 2000). CPAP users are also at reduced risk for motor vehicle 
accidents compared to non-CPAP users (Engleman, Asgari-Jirhandeh, McLeod, Ramsay, 
Deary, & Douglas, 1996; Young et al., 2002). Recent evidence suggests that CPAP may 
also be effective in reducing negative psychosocial and improving mental health outcomes 
of these patients (Fidan, Ünlü, Sezer, Geçici, & Kara, 2007). The reduced daytime 
sleepiness noted during CPAP treatment is also associated with improvements in general 
quality of life for both the patient (Weaver, Maislin, Dinges, Bloxham, George, Greenberg, 
et al., 2007) and their partner (Kiely & McNicholas, 1997; Kingshott et al., 2000; 
McMahon, Foresman, & Chisholm, 2003). Despite the numerous positive outcomes 
experienced by patients who use CPAP, the effectiveness of this treatment is limited by 
suboptimal adherence rates.  
Adherence to CPAP 
CPAP treatment of OSA can be awkward, and requires considerable alteration to a 
patient’s lifestyle (Malhotra et al., 2000). It has been estimated that 15 - 30% of patients do 
not accept CPAP treatment from the outset, that is, before or during their titration study 
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(Collard, Pieters, Aubert, Delguste, & Rodenstein, 1997; Fletcher & Luckett, 1991). This 
early pattern of CPAP use is critical for determining continued patterns of use (Weaver, 
Grunstein, 2008). Of those who do initially accept the treatment and take it home, 25 - 50% 
of patients fail to adhere optimally to the treatment (Zozula & Rosen, 2001). In the long 
term, up to 25% of patients stop using the treatment by the third year (Engleman & Wild, 
2003). 
Studies addressing adherence to CPAP up to five years follow-up, indicate that 
patients still using CPAP in the long term can be expected to use their CPAP machine, on 
average, between 4 and 5 hours per night at the prescribed pressure (Aloia, Arnedt, 
Stepnowsky, Hecht, & Borrelli, 2005; Bennet, Langford, Stradling, & Davies, 1998; 
Engleman et al., 1996; Engleman & Wild, 2003; Kingshott et al., 2000; Krieger, 1992; 
Lewis Seale, Bartle, Watkins, Watkins, & Ebden, 2004; Pieters, Collard, Aubert, Dury, 
Delguste, & Rodenstein, 1996; Reeves-Hoche, Meck, & Zwillich, 1994; Sage, Southcott, & 
Brown, 2001). A meter reading on CPAP machines provides an accurate measure of the 
number of hours that patients are using CPAP at pressure per night. Use of more than 4 
hours per night has been quantified in the literature as “good” adherence (Collard et al., 
1997; Haniffa, Lasserson, & Smith, 2004; Kingshott et al., 2000). However, this represents 
use of CPAP as prescribed for up to only half of the night. No dose-response definition for 
optimal CPAP use currently exists. However, recent research suggests that a linear dose-
response curve is appropriate, whereby greater use during sleep is associated with greater 
improvement in daily functioning and reduced daytime sleepiness (Weaver et al., 2007). 
Without dosing guidelines, clinician goals for patient adherence tend to be for the patient to 
use the device as much as possible whilst sleeping. 
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Patient-reported reasons for not using CPAP 
The reasons reported by patients for not using CPAP are usually associated with the 
side effects of the treatment. The most common side effects, reported in 15 to 45% of 
patients, are skin irritation, nose stuffiness and air leaks around the mask (Zozula & Rosen, 
2001). Less common, but equally significant reported problems, are claustrophobic 
reactions to the mask, problems with spontaneous intimacy with the bed partner, and the 
noise of the machine (Engleman et al., 1996; Hui et al., 2001; Zozula & Rosen, 2001). 
Specific modifications to the CPAP device and interface (such as humidifiers, pads on the 
bridge of the nose to reduce irritation and reduced noise from the machine) have lessened or 
removed many but not all of these side effects. However, there has not been a 
corresponding increase in adherence rates proportional to the amount of reduction in side 
effects experienced with these newer machines (Haniffa et al., 2004; Malhotra et al., 2000; 
Patel et al., 2003; Perlis & Lichstein, 2003; Stepnowsky, Marler, & Ancoli-Isreal, 2002). 
This suggests that the problem of CPAP adherence is not fully explained by mechanical 
issues with the CPAP device.  
Investigation of psychological and motivational factors in CPAP adherence has led 
to a shift in the focus of patient treatment. Targeting patient attitudes towards the treatment, 
and improving these, has become a viable research avenue (Brostrom, Stromberg, 
Martensson, Ulander, Harder, & Svanborg, 2007; Weaver & Grunstein, 2008). The 
following sections of this review will outline physiological and demographic predictors of 
CPAP adherence. Following this, recent research evidence investigating psychological 
modifiable predictors of CPAP adherence will be evaluated with the aim of identifying 
modifiable constructs that can be incorporated in the context of an inclusive theoretical 
model predictive of patient acceptance and adherence to treatment. 
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Physiological and Demographic Predictors of Adherence 
Many empirical studies have investigated general predictors of CPAP adherence. 
CPAP use may be associated with demographic factors such as male gender (Lewis et al., 
2004; McArdle et al., 1999; Popescu, Latham, Allgar, & Elliot, 2001; Zozula & Rosen, 
2001) lower age (McArdle et al., 1999; Zozula & Rosen, 2001) and the absence of a 
comorbid pulmonary disease (Lewis et al., 2004; McArdle et al., 1999). There is large 
variability in the literature regarding the predictive power of physiological indices of OSA 
severity.  
Greater adherence to CPAP appears to be associated with objective and subjective 
improvements in disease variables of sleep quality and daytime sleepiness (Collard et al., 
1997; Drake et al., 2003; Meurice et al., 1994; Popescu et al., 2001). Some studies have 
noted correlations (typically between r =.2 and r =.4) between the AHI and adherence 
(Drake et al., 2003; Edinger, Carwile, Miller, Hope, & Mayti, 1994; Engleman & Wild, 
2003; Hui et al., 2001; Krieger, 1992; Lewis et al., 2004; McArdle et al., 1999; Meurice et 
al., 1994; Popescu et al., 2001; Zozula & Rosen, 2001). Adherence is less consistently 
associated with lower prescribed CPAP pressure (CPAP pressure <12cm) (Engleman & 
Wild, 2003; Zozula & Rosen, 2001), higher BMI (BMI>30) (Edinger et al., 1994; McArdle 
et al., 1999; Popescu et al., 2001; Zozula & Rosen, 2001) and higher level of education 
(Hui et al., 2001; Kribbs et al., 1993).  
While demographic and physiological factors assist in the prediction of CPAP 
adherence, linear combinations of these physiological and demographic predictors rarely 
explain more than 10-15% of the variance in CPAP adherence (Engleman & Wild, 2003). 
Moreover, poor adherence rates are not specific to OSA or to CPAP. Studies of adherence 
to prescribed treatments for asthma (Bosley, Fosbury, & Cochrane, 1995), narcolepsy 
(Rogers, Aldrich, Berrios, & Rosenberg, 1997) and diabetes (Balkrishnan et al., 2003) have 
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shown that even with non-invasive pill or inhaler treatments with minor side effects, 40 - 
50% of patients do not take the medication as prescribed (Clark & Becker, 1998; DiMatteo, 
Giordani, Lepper, & Croghan, 2002). Therefore, although treatment adherence is a 
significant problem for OSA patients, it is not a problem unique to this syndrome. 
Motivational/Psychological factors in adherence to treatment 
In a variety of chronic disorders requiring consistent adherence to a treatment 
regime (for example: diabetes, asthma and heart disease), social, emotional, personality and 
cognitive factors have been found to enhance the prediction of adherence (Connor & 
Norman, 1996; Kavanagh, Gooley, & Wilson, 1993). Inclusion of psychological variables 
to physiological variables in predicting CPAP adherence has been found to substantially 
improve prediction (Edinger et al., 1994; Olsen, Smith, Oei & Douglas, in press; 
Stepnowsky, Bardwell, Moore, Ancoli-Isreal, & Dimsdale, 2002; Stepnowsky, Marler et 
al., 2002). Given these findings, there has been a call for the identification of psychological 
predictors of CPAP adherence that are amenable to intervention (Aloia, Arnedt, Riggs, 
Hecht, & Borrelli, 2004; Aloia et al., 2005; Drake et al., 2003; Engleman & Wild, 2003; 
Perlis & Lichstein, 2003). 
Psychological Predictors of Adherence 
Physiological indices of the severity of sleep disordered breathing (for example, 
AHI) are not reliably correlated with patients’ reported subjective symptom severity and 
quality of life (Chervin & Aldrich, 1999; ICSD-2, 2005; Zezirian, Harrison, Ancoli-Isreal, 
Redline, Ensrud, et al., 2007). This indicates that a patients’ subjective perception of the 
problem may not necessarily reflect the objective severity of the illness. Thus, objective 
severity may not reflect their need for treatment. The impact of these beliefs and 
motivations on CPAP use has only recently gained recognition within the OSA literature.  
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Table 1 reports studies assessing the impact of psychological factors on CPAP 
adherence returned from Psyc-Info and Medline and database searches of combinations of 
the keywords “Obstructive Sleep Apnea”, “Adherence” and “Psychology/Psychological”. A 
particular focus in Table 1 is given to the strength and utility of psychological constructs 
derived from a sound theoretical and research basis. Strengths and limitations of each study 
are identified, as are the strength of the association between each variable or combination of 
variables with adherence. In developing a unified theory of CPAP adherence, an emphasis 
is given to previous research assessing constructs in the context of theoretical models of 
adherence, the use of prospective data collection and adequate sample sizes.  
 
TABLE 1 HERE 
 
Daytime sleepiness is a prevalent feature of the syndrome (ICSD-2, 2005). As 
presented in Table 1, Epworth Sleepiness Score (ESS; Johns, 1991), a measure of 
subjective sleepiness, is an inconsistent predictor of adherence across the literature. Some 
studies have found it to predict adherence (Engleman et al., 1996) and self-referrals for 
CPAP treatment (Hoy et al., 1999). Other studies report no effect of ESS score prior to 
treatment on determining CPAP adherence (Hui et al., 2001; Olsen et al., in press; 
Stepnowsky, Marler et al., 2002). However, subjective improvements in daytime and 
nocturnal symptoms with treatment, as demonstrated by an improvement in ESS score, may 
predict ongoing CPAP use (Engleman et al., 1996; Lewis et al., 2004; McFadyen, Espie, 
McArdle, Douglas & Engleman, 2001).  
The degree to which patients report satisfaction with the treatment reliably 
correlates with adherence (Hui et al., 2001; Kribbs et al., 1993; Popescu et al., 2001). These 
subjective judgements of improvements in symptoms and daily functioning with treatment, 
as well as judgments about the severity of the associated side effects of the treatment, may 
CPAP Adherence and Intervention         11         
 
be associated with personality style. A recent study by Brostrom and colleagues (2007) 
indicated that characteristics of negative affectivity and social inhibition associated with 
“Type D” personality predicted greater reporting of side effects of the treatment, and 
subsequent poorer adherence.  
Generally, the contribution of psychological predictors of adherence support a 
conceptualisation of adherence as a balance between the subjective benefits of using CPAP 
as reported by the patient, versus the costs of using it. From the patient’s perspective, the 
side effects of the treatment may be a sufficient “cost” of the treatment to outweigh the 
benefits of using the treatment. 
Psychological Symptoms and CPAP adherence 
Fewer symptoms of anxiety and depression at pre-treatment may be associated with 
better subsequent CPAP adherence (Edinger et al., 1994; Lewis et al., 2004). Edinger and 
colleagues (1994) administered the MMPI to 28 male OSA patients as well as measures of 
daytime sleepiness and sleep quality before they had experienced CPAP. At six months 
follow-up, 63% of the variance in self-reported use of CPAP was explained by a 
combination of the MMPI hypochondriasis and depression scales, as well as BMI, 
sleepiness and sleep quality. Self-reported nightly CPAP use, rather than objective CPAP 
machine hours, was the adherence measure in this study. As self-reported use is highly 
subjective, the conclusions able to be drawn from this study are limited. In addition, the 
direction of the effect is unclear (Andrews & Oei, 2004). It is unknown whether use of 
CPAP improves depressive symptoms, and this change predicts ongoing use, or 
alternatively, whether ongoing depressive symptoms with treatment impacts on subsequent 
adherence (Wells, Day, Carney, Freedland, & Duntley, 2004). 
Stepnowsky, Bardwell and colleagues (2002) investigated the predictive value of 
psychological variables of pre-treatment anxiety, depression and coping variables in the 
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prediction of objective CPAP adherence. Twenty-three patients completed a psychological 
battery before experiencing CPAP, and adherence was measured at one week post-
treatment initiation. They found that anxiety and depression did not correlate with CPAP 
adherence at one week. However, patients who used “active” ways of coping with life 
situations before starting treatment used CPAP more at follow up. “Active” coping refers to 
a tendency to use active means to manage difficult situations. This would include being 
open to modifying one’s lifestyle for the treatment.  
The value of psychological variables, including anxiety and depression, in the 
prediction of CPAP adherence is currently unclear. However, this may be a reflection of the 
atheoretical and inconsistent ways in which these constructs have been investigated. Issues 
with acceptance of treatment are not uncommon in populations where individuals referred 
for treatment may have a low perceived need for treatment, for example, substance abusers. 
Within this framework, environmental, motivational and psychological factors have been 
identified as crucial to treatment acceptance (Katz et al., 2004; Satre, Knight, Dickson-
Fuhrmann, & Jarvik, 2004). 
Social Support and CPAP adherence  
A large proportion of OSA patients are married or in long-term relationships 
(McFadyen et al., 2001; Stepnowsky, Marler et al., 2002; Wild, Engleman, Douglas, & 
Espie, 2004). Spousal support has been identified as a potential mediating variable relating 
to treatment adherence in other health domains (Doherty, Schrott, Metcalf, & Iasiello-
Vailas, 1983; Jones, 2002). Of particular importance may be the spouse’s self-reported 
acceptance of a treatment (Doherty et al., 1983) and improvements in marital satisfaction 
with CPAP use (Kiely & McNicholas, 1997; McFadyen et al., 2001). More generally, 
partner support, relationship quality and self-efficacy have been found to be important 
predictors in cardiac patient’s compliance with rehabilitation (Jones, 2002). Consistent with 
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this, living alone has been identified as a potential predictor of poorer CPAP adherence 
(Lewis et al., 2004). The role of partner quality of life on CPAP adherence has not been 
addressed in previous research. Moreover, the role of marital satisfaction on CPAP 
adherence has only been addressed by one underpowered study (McFadyen et al., 2001). As 
such, the role of environmental factors such as social support and marital satisfaction on 
patient acceptance of CPAP treatment remains under researched.  
Theoretical Models of CPAP Adherence 
A limited number of studies have investigated explicit psychological models of 
adherence derived from other health domains (Aloia et al., 2005; Olsen et al., in press; Sage 
et al., 2001; Stepnowsky, Marler et al., 2002; Wild et al., 2004; Wong, 2001). Prediction of 
CPAP adherence from a theory driven perspective has reduced some of the inconsistency 
noted in previous research. As outlined in Table 1, Stepnowsky, Marler et al., (2002) and 
Aloia et al., (2005) have applied Bandura’s Social Cognitive Theory (SCT) (Bandura, 
1998) and the Transtheoretical Model (TTM) (Grimley, Prochaska, Velicer, Blais, & 
DiClemente, 1994) to the prediction of CPAP adherence.  Wild and colleagues (2004) 
utilised Wallston’s Health Locus of Control and Social Learning Theory (SLT) (Wallston, 
1992) to predict CPAP adherence before CPAP experience, while Olsen et al., (in press) 
and Sage and colleagues (2001) have applied constructs from the Health Beliefs Model 
(HBM) (Connor & Norman, 1996). 
Social Cognitive Theory (SCT) and Transtheoretical Model (TTM) 
Bandura’s SCT proposes that a patient’s expectations for good or bad outcomes if 
the appropriate health behaviour is undertaken, and their belief in their ability to engage in 
the necessary behaviours to affect change (self-efficacy), are predictive of their subsequent 
engagment in these behaviours (Bandura, 1998; Britt, Hudson, & Blampied, 2004; Clark & 
Becker, 1998). SCT also emphasises the importance of knowledge and social support in 
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adherence (Stepnowsky, Marler et al., 2002). TTM proposes that a patient’s readiness to 
engage in the required adherence behaviour (“readiness to change”) is important for 
subsequent adherence (Prochaska, Johnson & Lee, 1998). Patients are conceptualised as 
moving through five stages of increasing readiness to change, from pre-contemplation 
(patient has no intention of engaging in the required health behaviour), contemplation, 
preparation (preparing to engage in the health behaviour within the next month), action and 
maintenance. Finally, the patients’ subjective “weighing” of the pros and cons of the 
treatment (decisional balance) is also important in predicting adherence (Prochaska & 
DiClemente, 2005; Prochaska & Marcus, 1994). These models incorporate many aspects of 
the environmental, motivational and psychological factors identified in this review as 
important in predicting CPAP adherence. These include self-efficacy (Aloia et al., 2005; 
Sage et al., 2001), spousal support, and the patient’s subjective weighing of the pros and 
cons of the treatment. 
Stepnowsky, Marler and Ancoli-Isreal (2002) investigated SCT and TTM measures 
in predicting CPAP adherence at one-month post-CPAP fitting. They developed specific 
OSA measures assessing self-efficacy, outcome expectations, social support, knowledge 
and process of change and decisional balance. Significant relationships were found between 
the patient’s decisional balance after 1 week of using CPAP and adherence at 1 month. This 
relationship was predictive even when CPAP pressure was statistically controlled. SCT 
measures of self-efficacy and outcome expectancies also predicted adherence. While the 
SCT constructs measured at 1 week explained an additional 26% of the variance in CPAP 
adherence, the four measures did not individually predict adherence. This may suggest that 
inter-correlations between the predictors, rather than unique contributions of the predictors 
themselves, were responsible for predicting adherence. Therefore, CPAP adherence must be 
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considered from a perspective of model building and testing, with clear predictions as to the 
complex interrelationships between predictors.  
Aloia and colleagues (2005) found that readiness, self-efficacy and decisional 
balance, when measured at 1 week and three months after the patient had started CPAP, 
predicted CPAP adherence at 6 months. These constructs did not predict adherence when 
measured before experience with CPAP. That is, TTM and SCT predictors are not 
predictive in the initial stages of treatment, but become predictive as the patients’ exposure 
to the therapy increased. Readiness and self-efficacy were the most predictive constructs, 
explaining approximately 23% of the variance in CPAP adherence. Contrary to the research 
of Stepnowsky, Marler and colleagues (2002), decisional balance was only predictive of 
adherence at 6 months when measured at 1 week after commencing on CPAP. When 
objective adherence was included in the prediction equation, the TTM and SCT constructs 
failed to explain any additional variance. This suggests that objective early adherence 
predicts subsequent adherence, with TTM and SCT constructs adding little to the picture. 
That is, these psychological variables are confounded by actual CPAP use, as they are not 
predictive before the patient has gained at least one week of exposure to the treatment. 
Studies investigating the efficacy of TTM and SCT constructs in predicting CPAP 
adherence indicate that they add little variance above that explained by objective early 
adherence to the treatment. However, earlier research indicated that prediction of adherence 
before CPAP experience (treatment acceptance) using psychological variables is achievable 
(Edinger et al., 1994; McFadyen et al., 2001; Stepnowsky, Bardwell et al., 2002; Wild et 
al., 2004). This early prediction is vital, given that up to 30% of patients have already 
rejected the treatment before, or shortly after their titration study (Collard et al., 1997). 
Therefore, other models of adherence may be better able to explain why patients do not 
initiate or accept CPAP treatment (Olsen et al., in press). If psychological factors and 
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beliefs which impact on CPAP adherence are in place even before patient takes the device 
home, then the goal of treatment is to enhance patient acceptance of the treatment early in 
the assessment and treatment process, as well as support adherence later on.  
Social Learning Theory 
 Wallston’s modified SLT emphasises that the patient’s perception about the level of 
control they have over their illness will determine whether they change their behaviour to 
improve their health. Health Locus of Control is the central concept of this theory. This 
construct is subdivided into subscales of internality, powerful others and change. Patients 
who have a higher internal locus of control (i.e. they believe that they have control over 
their health) are more likely to adhere to treatment (Wallston, 1992; Wild et al., 2004). 
Patients with an external locus of control (i.e. they believe that their health is determined by 
external powerful others, such as a doctor, or is a matter of fate) will be less likely to 
adhere. The value one puts on their health (health value) is a moderator of the relationship 
between internal locus of control and health behaviour. That is, internal locus of control is 
only predictive of adherence when the patient values their health and their health outcome 
(Wallston, 1992). Finally, treatment specific self-efficacy, or the belief that one can 
effectively overcome obstacles to adherence, predicts adherence (Connor & Norman, 
1996). 
Wild and colleagues (2004) investigated SLT constructs of locus of control, 
generalised self-efficacy, and health value in 119 CPAP naïve OSA patients. It was found 
that general self-efficacy was not predictive of adherence at 3 months after commencing 
CPAP. In constrast, OSA disease specific variables of ESS, AHI, CPAP pressure and body 
mass index (BMI) predicted 18% of the variance in CPAP adherence. Internal locus of 
control as well as a lower belief in powerful others and more health value independently 
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predicted adherence. However, addition of the health locus of control and health value 
scales to the model only explained an additional 6% of the variance in adherence.  
There are several methodological issues raised by Wild and colleagues’ 
investigation of SLT. Although self-efficacy has been found to be a good predictor of 
adherence in other disorders (Connor & Norman, 1996; Jones, 2002), and is also predictive 
in other studies of OSA (Aloia et al., 2005; Sage et al., 2001), self-efficacy was not 
predictive in this study. However, a generalised self-efficacy measure was used for 
prediction. Research has shown that only a belief in ones ability to overcome barriers 
related to a specific treatment (treatment specific self-efficacy) is predictive of adherence to 
treatment (Connor & Norman, 1996). Therefore, Wallston’s modified SLT has not yet been 
investigated strictly according to theory and remains a potentially useful model. 
The Health Belief Model 
The Health Belief Model (HBM) has been successfully applied to the prediction of 
compliance to several disease models (Clark & Becker, 1998; Connor & Norman, 1996; 
Juniper et al., 2004) and has been applied to CPAP adherence prediction (Olsen et al., in 
press; Sage et al., 2001). HBM allows for the inclusion of demographic, psychological and 
psychosocial influences on adherence (Connor & Norman, 1996). Although developed for 
the prediction of engaging in preventative health behaviours (such as wearing bicycle 
helmets; Quine, Rutter, & Arnold, 2000) the theory has been modified for specific illnesses.  
According to HBM, the likelihood of engaging in health behaviour is based on 
readiness to act and expected benefit of the treatment. Readiness to act is determined by the 
patient’s belief in their susceptibility to the illness consequences if they left their illness 
untreated, as well as the perceived seriousness of their illness. The patient’s belief in the 
expected benefit of the treatment is based on their weighing of the perceived benefits to 
their health if they adhere to the treatment against the perceived barriers to action (Clark & 
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Becker, 1998; Connor & Norman, 1996; Quine et al., 2000). A cue to action, such as advice 
from a doctor, encouragement from the spouse, or a mass media campaign, acts as a trigger 
for the patient to commence healthy (adherence) behaviour (Quine et al., 2000). Self-
efficacy (confidence) in being able to use the treatment in the face of barriers, where 
barriers may present as side effects or the expense of the treatment, cements motivation to 
commence and continue with the treatment (Connor & Norman, 1996; Quine et al., 2000). 
 In a prospective study of 40 Australian OSA patients, Sage and colleagues (2001) 
developed a CPAP questionnaire assessing HBM constructs. Patients completed the 
questionnaire after CPAP titration, and adherence was measured at one month follow-up. It 
was found that perceived benefits of using CPAP and the patients’ belief in their ability to 
overcome obstacles to using CPAP (self-efficacy) were moderately positively correlated 
with CPAP adherence. Fewer concerns about barriers to using CPAP was also moderately 
correlated with CPAP adherence. Cues to action did not aid in the prediction of adherence. 
Overall, the HBM constructs of benefits and barriers were better predictors of CPAP 
adherence than the objective severity measures of RDI, BMI and CPAP pressure, 
explaining an additional 23% of the variance in adherence.  
This initial finding lends some support to the use of HBM constructs in the 
prediction of CPAP adherence. These constructs were predictive after only one night of 
CPAP experience (the titration study), indicating that the model may be of use in the early 
prediction of CPAP acceptance and adherence. A small sample size and use of HBM 
measures which were not empirically validated limitations the generalisability of the study. 
These psychological constructs show potential in the prediction of adherence for OSA. 
A further limitation of model testing in OSA to date is the use of simplistic, 
unidirectional regression models to predict relationships between psychological constructs 
and CPAP adherence. This approach overlooks the moderating and mediating relationships 
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between many of these variables. For example, the TTM constructs of readiness and 
decisional balance, as well as the SCT constructs of outcome expectations may be 
moderated by self-efficacy. That is, readiness may not be predictive of adherence when the 
patient lacks self-efficacy in being able to continue to use the treatment (Connor & 
Norman, 1996; Prochaska & Prochaska, 2004). These moderating relationships have not 
been addressed in studies previously applying psychological models to CPAP adherence. 
Rather, previous studies have successfully applied measures from these models in 
regression equations, but have not tested the models in a way that addresses the inter-
relationships between these constructs.  
A New Model of CPAP Acceptance and Adherence 
Our research group has attempted to overcome the limitations of this previous 
research and utilise the HBM in prediction of both CPAP acceptance and adherence (Olsen 
et al., in press). We utilised a theoretically grounded, conceptual model of CPAP 
acceptance and adherence developed from HBM constructs. Figure 1 presents this new 
model.  
INSERT FIGURE 1 HERE 
 
The previous adherence literature available (see Table 1) indicates that biomedical 
and psychological variables (such as depression and anxiety) do not directly influence 
CPAP adherence. These constructs indirectly influence adherence by adding to the patient’s 
perceived risk of negative health outcomes and the perceived severity of the disorder. This 
impacts on how the patient weighs the pros (benefits) and cons (barriers) of use, which in 
turn affects their acceptance of the treatment. HBM predictors of perceived risk, severity, 
benefits and barriers, in the presence of a cue to take action, directly predict acceptance of 
CPAP. The decision to accept CPAP as a treatment option then feeds back to inform the 
degree to which the patient perceives benefits and barriers to treatment, and their 
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confidence (self-efficacy) in being able to continue to adhere to the treatment. When 
combined with this feedback loop to the HBM constructs, CPAP acceptance will predict 
which patients continue to adhere to CPAP treatment at home. The basis of this model 
provides a foundation for informing the development of theoretically sound interventions 
for improving CPAP adherence. 
Our initial validation study of this model (Olsen et al., in press) investigated HBM 
constructs in the prediction of CPAP adherence early in the treatment process. Patients 
were provided a psychological questionnaire after a diagnosis of OSA but prior to starting 
CPAP. Thus, they were naïve to the experience of actual physical side-effects of the 
treatment. CPAP adherence was measured at 4 month follow up. We hypothesised that 
patients would begin to develop expectations and beliefs regarding OSA and CPAP even 
before its use and before taking the treatment home from the hospital. We expected that 
patients who had already developed negative beliefs regarding the effectiveness of the 
treatment, undervalued the likely benefit they would experience in daily functioning with 
its use, as well as had low perceived disease severity would not fully accept the treatment 
from the outset and thus would be unlikely to adhere as recommended to the treatment in 
the long term. We utilised existing, validated, measures of constructs from the model 
including self-efficacy, perceived risk (susceptibility), functional outcomes (severity) and 
outcome expectancies (benefits).  
 Consistent with the HBM, we found that patient’s expectancies regarding the 
effectiveness of the treatment (even prior to trying CPAP) predicted adherence at 4 months. 
Moreover, low perception of risk, and high perceived functional limitations due to 
sleepiness, such as in the areas of intimacy, activity levels and general productivity all 
uniquely predicted CPAP adherence. The HBM predictors explained 21.8% of the variance 
in CPAP adherence, whilst biomedical and HBM predictors together explained 31.8% of 
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variance in CPAP adherence. This supports previous research indicating that physiological 
measures of disease severity rarely independently predict more than 10% of the variance in 
CPAP adherence. Self-efficacy and psychological variables including depression, anxiety 
and stress did not directly predict CPAP adherence. 
 This initial validation of the HBM supports a call for early identification and 
support of patients with variables associated with low adherence, although there is still a 
great deal more work still needed in this area. The development and utilisation of validated 
measures to assess the model in its entirety are needed; namely, measures of barriers (side 
effects) and cues to action are required.  Larger sample sizes, utilisation of moderated 
regression techniques and potentially the development of “cut-off” values to determine 
“clinically significant” changes in beliefs and expectations are clear directions for future 
assessment of the HBM in treatment acceptance and adherence. 
Psychological Interventions for Improving CPAP Adherence 
Psychological constructs are most powerful in predicting CPAP use, and a number 
of these constructs have the potential to be changed or modified.  As CPAP modifications 
are now known to not improve adherence rates, resource allocation may be better targeted 
towards the identification of these modifiable, psychological predictors and then the 
development of interventions to specifically target them (Haniffa et al., 2004). Behavioural 
and cognitive behavioural interventions, as well as home support interventions and 
education have been used with this population (Aloia et al., 2004; Haniffa et al., 2004; 
Richards, Bartlett, Wong, Malouff, & Grunstein, 2007; Smith, Lang, Sullivan, & Warren, 
2004). Table 2 presents studies investigating educational and behavioural interventions in 
adult OSA populations published to date, along with between group effect size estimates. 
 
INSERT TABLE 2 Here 
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As demonstrated in Table 2, six education based interventions (Chervin, Theut, 
Bassetti, & Aldrich, 1997; Fletcher & Luckett, 1991; Golay et al., 2006; Hoy, Vennelle, 
Kingshott, Engleman & Douglas, 1999; Hui et al., 2000; Likar, Panciera, Erickson, & 
Rounds, 1997), and two Cognitive Behaviour therapy-based interventions (Aloia, Di Dio, 
Ilniczky, Perlis, Greenblatt, & Giles, 2001; Richards et al., 2007) have been reported in the 
literature.  
Education-based interventions have not consistently demonstrated their efficacy in 
improving CPAP adherence, with effect size estimates between intervention and control 
groups ranging from 0.14 to 0.99. Many of these studies utilise small sample sizes and lack 
a time-matched control group. However, the larger, better controlled and representative 
studies of Hui and colleagues (2000) and Chervin et al., (1997), indicate that basic 
education provided early in the treatment process, may improve subsequent adherence 
rates. Specifically, these education programs involve providing information to new CPAP 
users about how to appropriately use CPAP, and how to overcome side effects related to 
treatment.  
Hoy and colleagues (1999) reported 1.6 hours greater adherence for patients who 
received an additional CPAP titration night, education in their home which involved the 
partner, and regular follow-up visits for 4 months after treatment initiation compared to 
patients randomly assigned to standard CPAP support. The biggest effect size for change in 
CPAP adherence was noted by Chervin et al., (1997), who found that participants who 
received literature outlining the importance of regular CPAP use, used CPAP 2.7 hours 
more than a standard control group (d=.99), and 1.4 hours more than a group who received 
weekly trouble-shooting phone calls.  
The mechanisms by which changes in adherence behaviour occurs has not been 
directly tested. Education programs may increase patient self-efficacy in using the 
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treatment. They may also provide a vehicle for building patient’s beliefs in the expected 
health benefit to be derived if the treatment is used. Without direct measures of these 
constructs, there remains little validation for patient education as a method of modifying 
patient beliefs and expectations as is required to sustain adherence to treatment in the long 
term. 
Two studies have investigated the impact of Cognitive-Behaviourally and 
Motivational Interviewing orientated interventions on CPAP adherence, and compared 
these to standard care (Aloia and colleagues, 2001; Richards et al., 2007). As demonstrated 
in Table 2, large effect sizes of between 1.27 and 1.09 are demonstrated. Aloia and 
colleagues (2001) randomly assigned 12 OSA patients to either two sessions of brief 
instruction in the consequences of OSA and the efficacy of CPAP, or to a therapist time-
matched standard care condition. There was no difference in adherence between the groups 
at weeks one or four after treatment initiation. However, by 12 weeks of treatment, the CBT 
group were using CPAP an average 3.2 hours longer than participants in the control group 
(d=1.27). Moreover, despite a small sample size, which might account for the non-
significant differences noted between the groups at 1 and 4 weeks follow-up, appropriate 
randomisation of groups and a therapist time-matched control was used.  
Although presented as a cognitive-behaviourally based intervention, Aloia and 
colleagues (2001) describe a brief intervention more akin to Motivational Interviewing. In 
session 1 the advantages and disadvantages of the treatment, and pre-treatment PSG and 
other health symptoms are discussed before a goal for therapy is developed. Session 2 
entails trouble-shooting, review of goals for treatment and development of realistic 
expectations with treatment. As with the education based treatments presented earlier, the 
mechanisms of change are not delineated, thus, the components of the treatment which 
affect the greatest change in patient beliefs and behaviour cannot be determined. It is 
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possible that education about the treatment is sufficient to improve adherence rates. 
Alternatively, the development of specific goals for use and promoting realistic 
expectations for treatment may be the powerful components. Additional research is 
required to determine theoretically stable and powerful treatment components from which 
to build an intervention to improve CPAP adherence.  
Richards, Bartlett and colleagues (2007) also found a large effect size difference in 
treatment adherence in 50 patients who were randomly assigned to a group CBT 
intervention as compared to 50 patients who received treatment as usual (d=1.09). CBT 
consisted of group sessions including the patient and their partner, and targeted the 
identification and modification of faulty beliefs regarding the treatment. Moreover, videos 
showing “role models” persevering with the treatment were presented. Simple relaxation 
strategies were utilised to minimise anxious reactions as the patients tried on their masks. 
Participants who completed the two, one hour CBT interventions used CPAP 2.9 hours 
more per night at 28 days after starting CPAP. In addition, the CBT group reported higher 
self-efficacy and social support. Without the addition of a therapist time-matched control 
group, and without controlling for partner involvement in both interventions, it is difficult 
to identify the precise mechanism of change in this study, although there is good evidence 
that self-efficacy and social support were important factors in patient use of CPAP at 28 
days. The degree to which these changes persist in the long term is a target for future 
studies utilizing longer follow up time frames. This study represents the most rigorous 
study of this kind presented in the literature to date, and provides support for the use of 
psychological theory and intervention in targeting the problem of CPAP adherence.  
In summary, psychological interventions used to improve adherence to CPAP have 
provided promising results. Methodological limitations associated with these need to be 
addressed in further research. Specifically, small sample sizes, and an atheoretical 
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application of these interventions leaves the specific process of change involved with these 
open to interpretation. However, the better controlled studies of Aloia et al., (2001), Hoy et 
al., (1999), Chervin et al., (1997) and Richards et al., (2007) indicate that interventions 
designed to target motivational aspects of treatment acceptance, such as developing specific 
goals for CPAP use and building self-efficacy and a sense of social support, have some 
theoretical and empirical support for the problem of CPAP adherence. 
Motivational Interviewing  
Motivational Interviewing (MI) has gained recognition as an efficacious treatment 
for enhancing health behaviour for a variety of disorders, including reducing addictive 
behaviour such as smoking and alcohol dependence, and increasing treatment compliance 
(Burke, Arkowitz, & Menchola, 2003; Miller & Rollnick, 2002). MI is a client-centered 
therapy designed to enhance a patient’s readiness to change, or in the case of CPAP 
adherence, readiness to initiate and adhere to treatment.   
MI appears to be particularly relevant to the problem of CPAP adherence in OSA 
(Aloia et al., 2004) as it addresses the patient’s ambivalence regarding CPAP use and is 
consistent with several models of the models of behaviour change (Britt et al., 2004) which 
have been applied to CPAP. These include Social Cognitive Theory and TTM (Aloia et al., 
2005; Stepnowsky, Marler et al., 2002), Health Belief Model (HBM) (Sage et al., 2001) and 
SLT (Wild et al., 2004). All of these models share three constructs which provide the basis 
for MI. These constructs are; 1) the patient’s outcome expectations for using the treatment; 
2) the patient’s belief in their ability to engage in the behaviour (self-efficacy); and 3) the 
patient’s readiness to engage in the behaviour (Miller & Rollnick, 2002). The expected 
mechanism of change in this intervention is clear, precise and measurable. The use of MI 
with patients in the early phases of CPAP treatment shifts their focus from the negatives of 
the treatment to the positives of the treatment. This in turn theoretically increases their 
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motivation to start using CPAP, and continue using CPAP in the long term. Therefore, 
exploration of the efficacy of a CPAP specific MI intervention in improving CPAP 
adherence rates is both theoretically and practically sound. 
Directions for Future Research 
Psychological constructs and theory have a lot to offer the real problem of poor 
adherence in this very serious disorder. However, there remains large gaps and 
inconsistencies in the psychological literature. Table 3 presents the directions for research 
in the psychology of OSA identified in this review. First, the successful treatment of OSA 
is limited by suboptimal adherence rates to CPAP. However, there is limited validation for 
“optimal adherence” guidelines. The dosage of CPAP needed for effective treatment, 
beyond the assertion that better outcomes are achieved with more CPAP use is unclear. The 
critical treatment endpoints, whether decreased cardiac risk, decreased accidents at work or 
improved social functioning, need to be better explicated. In addition, while modifiable 
psychological and psychosocial predictors of CPAP adherence have gained some 
recognition in the literature, environmental factors such as social support and marital 
satisfaction are viable areas for improved quantitative research.   
The application of robust theoretical models to OSA research has substantially 
improved our understanding of the role of psychological constructs in CPAP adherence. 
However, additional large scale studies investigating diverse OSA populations are needed 
to further validate these models. At present, SCT and HBM are demonstrating considerable 
promise in explaining the problem of CPAP adherence. Moreover, SLT and TTM have also 
been tested, and demonstrate some promise for CPAP prediction. Continuing research 
should move beyond the current regression approach to analyses. Moderating and 
mediating relationships between psychological predictors and constructs within these 
models have potential to explain additional important variance in CPAP adherence. 
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Sophisticated testing of these models through quantitative statistical modeling is required 
for these internal motivational processes to be adequately assessed.  
The use of psychological and educational interventions for improving CPAP 
adherence is a largely understudied area of research, dominated by small, underpowered, 
studies with poor or highly variable methodologies. However, CBT-based interventions, as 
well as interventions designed to address the motivational aspects of CPAP use, such as 
Motivational Interviewing, can be directly tested through RCT’s, and are suggested as 
appropriate interventions for this population. 
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Figures 
 
 
  weak unidirectional relationship                  moderate to strong unidirectional relationship 
                                                                        moderate to strong bidirectional relationship 
 
Figure 1. A conceptual model of CPAP acceptance and adherence (modified from Clark & 
Becker, 1998; Olsen, Smith, Oei & Douglas, in press) 
CPAP Acceptance
* Perceived barriers 
* Perceived benefits
* Perceived risk of               
   negative outcomes 
* Perceived severity of  
   OSA 
* Biomedical indices (eg. RDI, BMI, Oxygen Desaturation) 
* Psychological variables (eg. Depression, Anxiety, Stress) 
Cue to action 
CPAP Adherence
Self-Efficacy 
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Table 1: Psychological Predictors of CPAP use  
Study Participants Methodology Outcomes Strength of 
Association 
Comments 
Aloia et al., 2005 98 (65 male) 
mean age=51.4 years 
mean education=14.6 years 
mean AHI=39.8 events/hour 
mean BMI=33.8 kg/m2 
mean CPAP pressure=10.2 
cmH2O 
 
 
Theory: Measures of the TTM model and 
SCT model, including readiness, decisional 
balance, and self-efficacy. 
Testing: Psychological battery at baseline 
(after CPAP titration but before treatment 
initiation), three months follow-up, and six 
months follow-up. 
70 participants also completed the battery at 
1 week follow-up 
 
Baseline: Readiness, self-efficacy and decisional 
balance did not predict adherence at 6-months  
1 week follow-up: TTM/SCT measures predicted 
adherence. Readiness and self-efficacy most 
predictive. 
3 month follow-up: TTM/SCT measures predicted 
adherence. 
Objective use explained 52% and 78% variance in 
6 month adherence. TTM and SCT measures did 
not improve prediction above objective adherence 
R2=.066 
 
R2=.232 
 
 
R2=.415 
• Well controlled, 
prospective study 
• Well defined 
constructs 
Brostrom et al., 
2007 
247 (203 male) 
74 “Type D personality” 
173 “non-Type D personality” 
mean age=60 years 
mean AHI (Type D personality)= 
50.8 
mean AHI (non-Type D 
personality)= 47.1 
mean ESS (Type D)= 11.7 
mean ESS (non-Type D)= 12.0 
Theory: Measures of Type D (distressed) 
personality including negative affectivity and 
social inhibition. 
Testing: Questionnaire collecting 
demographic data, personality type, side 
effects and adherence to CPAP treatment 
posted to eligible patients who had been 
using CPAP more than 6 months. 
30% of patients categorized as “Type D 
personality” 
Type D personality reported significantly more 
side-effects with treatment 
Adherence was significantly lower for Type D 
patients compared to patients without Type D 
 
 
 • Cross-sectional study 
• Good sample size 
Drake et al., 2003 71 (43 male)  
mean age=50.7 
Testing: 5-factor personality inventory  
completed during first clinic visit. 
Mean follow-up period was 46.9 days 
(ranging between 1 and 2 months) 
 
Improved sleep quality between diagnostic and 
titration PSG associated with objective adherence.  
Five factor personality inventory not predictive of 
adherence. 
 
 
 
• Well controlled, 
prospective study 
• Good sample size 
 
 
Edinger et al., 1994 38 male veterans   
mean age=53 
mean education=12.1 years 
mean RDI= 42.9 
 
Testing: MMPI completed prior to CPAP 
experience 
CPAP use at 6 month follow-up assessed  
28 participants retained for analysis. 
Divided into “compliers” (N=20) and “non-
compliers” (N=8). 
Compliers had a higher BMI, lower subjective 
sleepiness, better sleep quality prior to treatment 
and lower depression and hypochondriasis scores. 
 
 
 
R2=.63 
• Prospective study 
• Self-reported use of 
CPAP used as 
adherence measure 
• Small, specific sample 
 
Engleman et al., 
1996 
204 (187 male) 
mean age=53 
mean AHI=47 
Testing: Patients using CPAP for a 
minimum 2 weeks. 
mean duration CPAP treatment=632 days 
(range=16 to 2921) 
   Pre-treatment ESS 
Post-CPAP ESS 
Nuisance problems with CPAP use 
Mask Problems 
Udaytime function 
U nocturnal symptoms 
Ugeneral functioning 
r=.22 † 
r=-.18† 
r=-.15† 
r=.17† 
r=.44† 
r=.35† 
r=46† 
 
• Cross-sectional study 
• Self-reported use of 
CPAP used as 
adherence measure 
• Limited psychological 
predictors assessed 
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Study Participants Methodology Outcomes Strength of 
Association 
Comments 
Hui et al., 2001 112 (101 male) 
mean age=45.6 
mean BMI=29.3 
mean AHI=48 
Testing: Assessed on variables and 
adherence at 1 month and 3 months post 
treatment initiation. 
Expense, inconvenience and nasal 
blockage/dryness were the main concerns. 
1 month follow-up 
                                                          ESS  
Education 
Satisfaction with CPAP 
 3 month follow-up 
                                                     ESS 
                                                         U ESS  
                                                              Education  
Satisfaction 
 
 
 
r =.02 
r =.07 
r =.35 
 
r =.06 
r =.1 
r =.09 
r =.15 
• Well controlled, 
prospective study 
 
Kjelsberg et al., 
2005 
178 (135 male) 
mean age=55.5 
mean BMI=31.1 
mean AHI=29 
 
Testing: Retrospective mail out of 
questionnaire  
Compliance defined at >3 nights use/week. 
Non-compliance predictive of symptoms of anxiety 
and depression. 
 • Cross-sectional study 
• Compliance based on 
days of use rather than 
hours per night 
Kribbs et al., 1993 35 (29 male) 
mean age=46.2 
mean BMI=39.5 
mean RDI=65.1 
mean pressure=12.9 
Testing: Pre- and post-treatment 
questionnaire assessing CPAP side effects 
and satisfaction with treatment 
Divided into “regular users” (N=16) and “irregular 
users” (N=19) (>4 hours on >70% of days). 
Compliance associated with: 
Daytime energy levels 
Satisfaction with CPAP treatment 
Regular users had: 
More years of education 
Higher daytime energy levels on CPAP treatment 
Greater satisfaction with CPAP treatment 
 
 
 
 
r =.39 
r =.44 
• Prospective study 
• Small sample size 
 
Lewis et al., 2004 70 (66 male) 
mean age=51 
mean BMI=35.5 
mean AHI=25.1 
 
 
Testing:  Semi-structured interview and the 
Hospital Anxiety and Depression scale 
following titration (baseline). 
Followed for a median 31 days (range= 11-
121 days). 
Participants who rejected CPAP following 
titration were excluded from analyses. 
No baseline variable significantly associated with 
CPAP use at 1 month. Change in ESS and anxiety 
and depression symptoms from baseline did predict 
adherence 
                                                 U ESS 
U Depression 
                                                        U Anxiety  
Division of participants into “compliers” (>4hrs 
use) and “non-compliers”. Experiencing a recent 
life event, reporting initial problems with the 
treatment during titration, and living alone 
associated with poorer adherence 
 
 
 
 
 
 
 
 
 
r =-.38 
r =-.38 
r =-.30 
• Well controlled, 
prospective study 
• Good sample size 
 
CPAP Adherence and Intervention         42         
 
Study Participants Methodology Outcomes Strength of 
Association 
Comments 
McFadyen et al., 
2001 
44 CPAP users and their partner 
(34 male OSA patients) 
mean age=49 
mean AHI=46 
Testing: Completed questionnaires before 
titration (baseline) and 3-months post 
titration. 
Patient questionnaires included marital 
satisfaction, general health/functional status, 
and sleep specific quality of life (FOSQ). 
Partner questionnaire included marital 
satisfaction only 
 
Primary physiological variables, and psychological 
variables at baseline and follow-up not predictive 
of adherence 
Change scores for psychosocial variables correlated 
with compliance, except for patient marital 
satisfaction. 
U Partner Marital Satisfaction 
U FOSQ 
U Epworth 
 
 
 
 
 
 
r=.31 
r=.57 
r=-.46 
• Well controlled, 
prospective study 
Meurice et al., 1994 44 (39 male)  
mean age=58 
mean BMI=34.9 
mean AHI=52 
mean pressure=9.68 
 
 
 
 
Testing: Equipped with a standard mask 
following CPAP titration. 
Followed for a mean 14 months after 
treatment (range=8-39 months). 
Patients divided into “compliant” (N=30) (>5hrs) 
and non-compliant (N=14) groups. Compliers 
reported fewer side effects and were aware of the 
benefits of using CPAP. 
 • Prospective study 
• Small sample size 
 
Olsen et al., in press 77 (47 male) 
mean age=55.25 
mean BMI=35.11 
mean RDI=38.36 
mean pressure=11.68 
Theory: Measures of Health Beliefs Model 
(HBM) used to predict adherence at 4 
months. CPAP questionnaire measured 
outcome expectancy with treatment, self-
efficacy, functional outcomes of sleepiness, 
and perceived risk of negative health 
outcomes. 
Testing: Participants completed 
questionnaire before titration (naïve to 
CPAP). Followed up 4 months post-
treatment initiation 
Primary physiological variables, and psychological 
variables (depression, anxiety and stress) at 
baseline not predictive of adherence 
Patient’s outcome expectancies prior to using 
CPAP, perception of risk, as well as perceived 
functional limitations due to sleepiness all uniquely 
predicted CPAP initiation and adherence 
Use at 4 month follow up associated with: 
                     Health Beliefs Model constructs alone  
                     Health Beliefs Model constructs with  
                     biomedical indices 
 
 
 
 
 
 
R2=21.8 
 
R2=31.8 
• Well controlled, 
prospective study 
• Sound theoretical basis 
and validated 
measures of constructs 
• Adequate sample size 
• Model yet to be fully 
assessed 
Popescu et al., 2001 209 (190 male) 
mean age=51 
mean AHI=38.1 
mean BMI=34.6 
 
Testing: 2 week trial of CPAP following 
titration. Satisfaction, problems with 
treatment and adherence assessed at end of 
trial. Followed for 12 months. 
Acceptance of CPAP associated with lower ESS at 
end of loan and greater subjective improvement in 
symptoms from pre to post trial. 
Continued use at 12 months associated with lower 
ESS at end of loan and higher ratings of symptom 
improvement. 
Use at one year weakly associated with: 
use during loan period 
ESS during loan 
                                                      ESS at 1 year 
 
 
 
 
 
 
 
r =.299 
r =-.299 
r =-.201 
 
• Well controlled, 
prospective study 
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Sage et al., 2001 40 (30 male) 
mean age=54.13 
Theory: Measures of Health Beliefs Model 
(HBM) and treatment specific Self-efficacy 
used to predict adherence at 1 month. 
CPAP questionnaire measured susceptibility, 
barriers, cues to change (symptom severity 
etc) and self-efficacy. 
Testing: Participants completed 
questionnaire after they had undergone 
education for CPAP use, and given CPAP 
machine. 
 
 
 
 
 
Susceptibility 
                                                    Severity  
                                                    Benefits 
                                                   Barriers 
                                                           Self-efficacy 
Psychological variables better predictors than 
objective severity measures (RDI, BMI & CPAP 
pressure). 
 
r =.10 
r =.15 
r =.32 
r =-.35 
r =.44 
• Prospective study 
• Small sample size 
• Measures used to 
assess HBM constructs 
not empirically 
validated 
Stepnowsky, 
Bardwell et al., 2002 
23 (16 male) 
mean age=47.1 
mean BMI=32.6 
mean RDI=54.2 
mean pressure= 10.2 
Theory: Used coping variables as predictors 
of adherence. 
Testing: Before experience with CPAP, 
patients completed the Ways of Coping 
Questionnaire and Berkman Social Support 
Scale, as well as the CES-D, POMS, BD, 
CM, STA and ESS. 
Adherence measured at the end of the first 
week of treatment. 
 
 
 
 
 
 
 
Depression 
                                                           Anxiety  
                                                         Stress  
Berkman Social Support 
                                                     BD  
Ways of Coping 
Relationship between ESS and RDI with adherence 
not significant.  
Addition of Ways of Coping improved prediction. 
r =-.017 
r =-.181 
r =-.004 
r =-.031 
r =.129 
r =.607 
 
R2adj=.148 
R2adj=.349 
• Prospective study, 
sound methodology 
• Small sample size 
 
Stepnowsky, Marler 
et al., 2002 
51 (49 male) 
mean age=54.1 
mean=36.4 
mean=40.4 
mean pressure=9.1 
Theory: SCT (self-efficacy, outcome 
expectations, social support and knowledge) 
and TTM (processes of change and 
decisional balance index) scales developed 
for study.  
Testing: Questionnaires completed at CPAP 
fitting (baseline), 1 week post treatment 
initiation, and 1 month post initiation. 
 
Baseline 
SCT and TTM models, when controlling for CPAP 
pressure, did not significantly predict adherence. 
1 week follow-up 
CPAP pressure and ESS did not significantly 
predict adherence. 
Addition of SCT model improved overall 
prediction 
Addition of TTM (decisional balance) to CPAP 
pressure and ESS improved prediction. 
1 month follow-up 
Controlling for CPAP pressure, SCT model 
significant 
Relationship between TTM and adherence 
significant at 1 month. 
Decisional Balance best predictor of adherence 
 
 
 
 
 
R2adj=.048 
 
 
R2adj=.309 
 
 
R2adi=.240 
 
R2adj=.40 
 
R2adj=.33 
• Well controlled, 
prospective study 
• Sound theoretical basis 
and validated 
measures of constructs 
• Only a veteran 
population used 
• More male participants 
than is usually 
represented in an OSA 
population 
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Wild et al., 2004 119 (94 male) 
mean age=51 
mean BMI=33 
mean AHI=45 
mean pressure=9 
mean ESS=13 
Theory: Measures from Wallston’s SLT 
(MHLC, Health Value scale and GSES).  
Testing: Questionnaire completed before 
CPAP titration. Adherence measured at 3 
months post treatment initiation 
Logistic regression comprising clinical variables 
(AHI, ESS, BMI & CPAP pressure) and 
psychological variables (MHLC and health value. 
GSES not included in model). 
Clinical predictors in model only: 
Clinical predictors with psychological variables did 
not substantially improve prediction. 
Health value the only psychological variable to 
significantly contribute.  
 
 
 
 
R2=.18 
 
R2=.24 
• Well controlled, 
prospective study 
• Psychological testing 
based on sound 
theoretical basis 
Key: U= Change; †=rank correlations    BD: Buss-Durkee Hostility Scale; CES-D: Center for Epidemiological Studies- Depression scale; CM: Cook-Medley Hostility Scale; 
ESS: Epworth Sleepiness Scale;  FOSQ: Functional Outcomes of Sleep Questionnaire; GSES: Generalised Self-efficacy Scale; MHLC: Multidimensional Health Locus of 
Control Scale; MMPI: Minnesota Multiphasic Personality Inventory; POMS: Profile of Mood States; RDI: Respiratory Disturbance Index; SCT: Social Cognitive Theory; 
SLT: Social Learning Theory; STA: Spielberger Trait Anxiety Scale; TTM: Transtheoretical Model. 
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Table 2: Educational/Behavioural Interventions for increasing CPAP use  
Study Participants Methodology Outcomes Strength of 
Effect 
Comments 
Aloia et al., 
2001 
12  
mean age=65.5 
mean AHI=43.5 
Randomly assigned to groups 
(stratified by age, education, disease 
severity and vigilance). 
Group 1 (N=6) cognitive-
behavioural intervention: two 45-
minute sessions educating patients 
on illness consequences and the 
efficacy of CPAP. 
Group 2 (N=6): standard therapist 
time-matched control with no 
education about OSA or CPAP. 
Adherence measured at 1, 4, and 12 
weeks post treatment initiation. 
Week 1 
Mean use in CBT=5.2 
hr/night 
Mean use in standard 
support=5.2 hr/night 
Week 4 
Mean use CBT=6.3 
Mean use control=5.0 
(difference not 
significant). 
Week 12 
Mean use CBT=7.8 
Mean use control=4.6 
(significant difference). 
 
 
d=0.30 
 
 
 
 
d=0.56 
 
 
 
 
d=1.27 
• Brief CBT focussed 
intervention effective 
by week 12. 
• Small sample size. 
• Good methodology, 
time-matched control 
group. 
Chervin et 
al., 1997 
33 (21 male)  
mean age=51.7 
10 patients were 
newly diagnosed 
with OSA.  
12 patients were 
continuing CPAP 
users. 
 
Randomly assigned to groups. 
Group 1 (N=12) telephone support: 
one telephone call per week asking 
about problems and encouraging 
nightly use. 
Group 2 (N=14) literature 
intervention: fact sheet about OSA 
and snoring and guidelines for 
CPAP use. 
Group 3 (N=7): no additional 
intervention  
Contacted 1 and 2 months post 
intervention. 
 
Mean use in 
literature=7.1 
Mean use in telephone 
support =5.7 
Mean use in control 
group =4.4 
Mean use continuing 
patients=6.29 
Mean use new 
patients=5.88 
(difference not 
significant). 
 
(compared to 
control group) 
d=.99 
 
d=.45 
 
 
 
• Education focussed 
intervention 
effective. 
• Intervention more 
beneficial for patients 
with lower education. 
• Small sample size. 
• No measure of 
treatment integrity. 
• Half of the sample 
were continuing 
patients. 
 
Fletcher & 
Luckett, 
1991 
7 male  
mean age=51.6 
mean AI=49 
Alternating assignment to telephone 
reinforcement group or control. 
After 3 months, groups swapped. 
Group 1 telephone reinforcement: 
called weekly for 3wks, then 
monthly for 2 months. Talked about 
severity of disease, complications of 
apnea, benefits of nCPAP and 
suggestions for minimising side 
effects.  
Group 2 control: called once per 
month for check up on mechanical 
problems etc. 
Mean use reinforcement 
period =5.95  
Mean use non-
reinforcement period 
=6.04 
 
 
 
 
• Education based 
intervention not 
effective.  
• Small sample size 
• No random 
assignment to groups 
 
Golay et 
al., 2006 
35 (22 male) 
mean age=58.3 
mean BMI=34.9 
mean AHI=49.7 
mean CPAP 
pressure=8.6 
 
Mean length of 
time using CPAP 
before 
intervention=323 
days 
Patients were enrolled in an 
inpatient group program targeting 
benefits of using CPAP, 
inconveniences associated with 
CPAP and practice with use of the 
machine 
Mean use at 
Baseline=4.4 
Mean use 3 months 
after program=5.1  
 
 
• Group based 
education program 
effective 
• Small sample size 
• No random 
assignment to groups 
 
Hoy et al., 
1999 
80 (78 male) 
mean age=51 
mean BMI=33  
mean AHI=58  
 
Randomly assigned to groups. 
Group 1 standard CPAP support 
Group 2 intensive support: included 
usual support plus 2 extra nights of 
titration (total=3), education in 
patient’s home involving partner, 
home visits by nurses at 7, 14, 28 
days and 4 months after initiation. 
Adherence measured at 6 months 
Mean use Intensive 
Support = 5.4 
Mean use Standard 
Support= 3.8. 
40% improvement in 
adherence continued at 
6 months. 
 
d=0.67 
• Education based 
intervention 
effective. 
• Good sample size 
and methodology 
• No time-matched 
control group 
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Study Participants Methodology Outcomes Strength of 
Effect 
Comments 
Hui et al., 
2000 
108 (97 male) 
mean age=45 
mean BMI=30  
mean AHI=48  
  
Randomly assigned to groups.  
Group 1 Basic CPAP education: 
mask fitting and short CPAP trial. 
Followed-up at 1 and 3 months. 
Group 2 Augmented Support: Basic 
education+ extra education about 
OSA and CPAP via 15 min video. 
Nurses followed-up by telephone on 
days 1 and 2, and on weeks 1, 2, 3, 
4, 8 and 12. 
1 month 
Mean use Augmented= 
5.5 
Mean use Basic =5.3 
(difference not 
significant) 
No difference at 3 
months. 
Greater Quality of Life 
improvement in 
Augmented Support 
group at 1 and 3 month 
follow-up. 
 
 
d=.14 
• Augmented 
education based 
intervention not 
additionally effective 
than basic education. 
• Good sample size 
and methodology. 
Likar et al., 
1997 
34 male  
mean age=58 
mean BMI=37 
mean AHI =34 
mean CPAP 
pressure =12 
 
Mean length of 
time using CPAP 
before 
intervention=463 
days. 
 
Evaluation of standard care group 
education sessions. 
8 to 10 patients per 2 hour session 
(afternoon) scheduled every six 
months. 
Session involved: 
Pulmonary care nurse instruction on 
OSA diagnosis, CPAP use and 
cleaning. Videotape on assembly, 
cleaning, adjustments and 
accessories for the CPAP machine. 
Encouraged to ask questions and 
compare experiences. 
 
Mean use after first 
clinic increased from 
5.2 to 6.3 hr/ night 
29% of patients 
increased use by 2 hr/ 
night 
6% decreased use by 2 
hr/night 
Results sustained over 3 
years. 
 
 
 • Education based 
intervention 
effective. 
• Retrospective Chart 
Review. 
• No Control group. 
• Did not control for 
number of clinics 
attended. 
Richards et 
al., 2007 
100 (96 male)  
mean age=56 
mean BMI= 30 
mean RDI= 25 
(CBT group), 27 
(TAU) 
mean ESS= 10 
 
Randomly assigned to TAU (50) or 
CBT group (50) 
CBT intervention: components of 
SCT (increased 
perceived self-efficacy, outcome 
expectations, and social support). 
Involved 2 one-hour sessions spaced 
1 week apart with 10 participants 
and their partners in each session 
28 days 
Mean use CBT=5.38 
Mean use TAU=2.51 
 
d=1.09 
• Brief Cognitive and 
Behavioural 
Intervention 
including partner was 
effective 
• Good sample size 
and methodology 
• No time-matched 
control group 
Key:  
CBT: Cognitive Behavior Therapy; SCT: Social Cognitive Theory; TAU: Treatment as Usual 
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Table 3. Directions for Future Research 
1. Dosing guidelines for objectively defining optimal CPAP adherence 
2. Role of partner support and general social support in CPAP adherence 
3. Further investigation of psychological models of CPAP adherence 
4. Further Randomised Control Trials of theory driven psychological interventions for 
improving CPAP adherence 
 
 
